Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURVE-UC: CurQD With Vedolizumab in Moderate to Severe Ulcerative Colitis
NCT07665294Phase 4Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 2
01
Overview
A Phase 4 trial of curcumin + qingdai in ulcerative colitis (UC). Planned start Oct 2026; status: not yet recruiting.
02
Drugs
curcumin + qingdai
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07665294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07665294.